Glycobiology Advance Access originally published online on August 31, 2005
Glycobiology 2006 16(1):54-64; doi:10.1093/glycob/cwj033
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity
2 Unité de Glycobiologie Structurale et Fonctionnelle, UMR CNRS n° 8576, GDR CNRS n° 2590, Université des Sciences et Technologies de Lille, F-59655 Villeneuve dAscq, France; 3 Laboratoire de Biologie du Développement, INSERM ERI8, UPRES EA 1033, Université des Sciences et Technologies de Lille, F-59655 Villeneuve dAscq, France; 4 Center of Biochemistry and Center for Molecular Medicine Cologne, University of Cologne, Joseph-Stelzmann-Street 52, D-50931 Cologne, Germany; and 5 Centre Commun de Mesures Imagerie Cellulaire, Université des Sciences et Technologies de Lille, F-59655 Villeneuve dAscq, France
1 To whom correspondence should be addressed; e-mail: philippe.delannoy{at}univ-lille1.fr
Received on July 6, 2005; revised on August 23, 2005; accepted on August 24, 2005
Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers, including breast cancer, and usually associated with poor prognosis. Sialyl-Tn is synthesized by a CMP-Neu5Ac:GalNAc
2,6-sialyltransferase: CMP-Neu5Ac: R-GalNAc
1-O-Ser/Thr
2,6-sialyltransferase (EC 2.4.99.3
[EC]
) (ST6GalNAc I), which transfers a sialic acid residue in
2,6-linkage to the GalNAc
1-O-Ser/Thr structure. However, established breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn. We have previously shown that stable transfection of MDA-MB-231, a human breast cancer cell line, with ST6GalNAc I cDNA induces sialyl-Tn antigen (STn) expression. We report here the modifications of the O-glycosylation pattern of a MUC1-related recombinant protein secreted by MDA-MB-231 sialyl-Tn positive cells. We also show that sialyl-Tn expression and concomitant changes in the overall O-glycan profiles induce a decrease of adhesion and an increase of migration of MDA-MB-231. Moreover, STn positive clones exhibit an increased tumour growth in severe combined immunodeficiency (SCID) mice. These observations suggest that modification of the O-glycosylation pattern induced by ST6GalNAc I expression are sufficient to enhance the tumourigenicity of MDA-MB-231 breast cancer cells.
Key words: breast cancer / cell adhesion / sialyl-Tn / ST6GalNAc I / tumour growth
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Ju, G. S. Lanneau, T. Gautam, Y. Wang, B. Xia, S. R. Stowell, M. T. Willard, W. Wang, J. Y. Xia, R. E. Zuna, et al. Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc Cancer Res., March 15, 2008; 68(6): 1636 - 1646. [Abstract] [Full Text] [PDF] |
||||
